Literature DB >> 7805054

Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5.

B Casu1, G Grazioli, N Razi, M Guerrini, A Naggi, G Torri, P Oreste, F Tursi, G Zoppetti, U Lindahl.   

Abstract

O-Sulfation of sulfaminoheparosan SAH, a glycosaminoglucuronan with the structure-->4)-beta-D-GlcA(1-->4)-beta-D-GlcNSO3(-)-(1-->, obtained by N-deacetylation and N-sulfation of the capsular polysaccharide from E. coli K5, was investigated in order to characterize the sulfation pattern eliciting heparin-like activities. SAH was reacted (as the tributylammonium salt in N,N-dimethylformamide) with pyridine-sulfur trioxide under systematically different experimental conditions. The structure of O-sulfated products (SAHS), as determined by mono- and two-dimensional 1H and 13C NMR, varied with variation of reaction parameters. Sulfation of SAH preferentially occurred at O-6 of the GlcNSO3- residues. Further sulfation occurred either at O-3 or at O-2 of the GlcA residues, depending on the experimental conditions. Products with significantly high affinity for antithrombin and antifactor Xa activity were obtained under well-defined conditions. These products contained the trisulfated aminosugar GlcNSO3-3,6SO3-, which is a marker component of the pentasaccharide sequence through which heparin binds to antithrombin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805054     DOI: 10.1016/0008-6215(94)00172-3

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  19 in total

1.  Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Authors:  Zhenyu Wang; Bo Yang; Zhenqing Zhang; Mellisa Ly; Majde Takieddin; Shaker Mousa; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-12       Impact factor: 4.813

2.  New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.

Authors:  H B Nader; E Y Kobayashi; S F Chavante; I L Tersariol; R A Castro; S K Shinjo; A Naggi; G Torri; B Casu; C P Dietrich
Journal:  Glycoconj J       Date:  1999-06       Impact factor: 2.916

3.  Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin.

Authors:  Zhenyu Wang; Jennifer Li; Samantha Cheong; Ujjwal Bhaskar; Onishi Akihiro; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  J Biotechnol       Date:  2011-09-10       Impact factor: 3.307

4.  Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Authors:  Antonella Bugatti; Cinzia Giagulli; Chiara Urbinati; Francesca Caccuri; Paola Chiodelli; Pasqua Oreste; Simona Fiorentini; Alessandro Orro; Luciano Milanesi; Pasqualina D'Ursi; Arnaldo Caruso; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

5.  Characterization of uniformly and atom-specifically (13)C-labeled heparin and heparan sulfate polysaccharide precursors using (13)C NMR spectroscopy and ESI mass spectrometry.

Authors:  Thao K N Nguyen; Vy M Tran; Xylophone V Victor; Jack J Skalicky; Balagurunathan Kuberan
Journal:  Carbohydr Res       Date:  2010-08-21       Impact factor: 2.104

Review 6.  High-field NMR as a technique for the determination of polysaccharide structures.

Authors:  B Mulloy
Journal:  Mol Biotechnol       Date:  1996-12       Impact factor: 2.695

7.  Biosynthesis of heparin/heparan sulphate: mechanism of epimerization of glucuronyl C-5.

Authors:  A Hagner-Mcwhirter; U Lindahl; J p Li
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

8.  Preparation and characterization of (15)N-enriched, size-defined heparan sulfate precursor oligosaccharides.

Authors:  Crystal Sigulinsky; Ponnusamy Babu; Xylophone V Victor; Balagurunathan Kuberan
Journal:  Carbohydr Res       Date:  2009-11-03       Impact factor: 2.104

9.  Solution structures of chemoenzymatically synthesized heparin and its precursors.

Authors:  Zhenqing Zhang; Scott A McCallum; Jin Xie; Lidia Nieto; Francisco Corzana; Jesús Jiménez-Barbero; Miao Chen; Jian Liu; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

10.  Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide.

Authors:  Debora Pinna; Pasqua Oreste; Tiziana Coradin; Anna Kajaste-Rudnitski; Silvia Ghezzi; Giorgio Zoppetti; Antonella Rotola; Rafaela Argnani; Guido Poli; Roberto Manservigi; Elisa Vicenzi
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.